|
|
|
Volumn 18, Issue 3, 2006, Pages 20-27
|
|
Biopharmaceuticals market overview
a
a
EMEA
*
(United Kingdom)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALTEPLASE;
BETA1A INTERFERON;
BEVACIZUMAB;
CINACALCET;
ETANERCEPT;
HUMAN GROWTH HORMONE;
HUMAN INTERFERON;
NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;
OMALIZUMAB;
RECOMBINANT ERYTHROPOIETIN;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
RITUXIMAB;
SOMATREM;
TENECTEPLASE;
TRASTUZUMAB;
ASIA;
BIOTECHNOLOGY;
CANCER RESEARCH;
CLINICAL PHARMACOLOGY;
DRUG APPROVAL;
DRUG COST;
DRUG INDUSTRY;
DRUG LEGISLATION;
DRUG MANUFACTURE;
DRUG MARKETING;
DRUG RESEARCH;
DRUG SURVEILLANCE PROGRAM;
EUROPE;
INVESTMENT;
PHARMACOGENOMICS;
REVIEW;
UNITED STATES;
|
|
EID: 33744459014
PISSN: 01646826
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (4)
|
|
References (0)
|
